| # | Drug | Count |
|---|---|---|
| 0 | DONEPEZIL HYDROCHLORIDE | 92 |
| 1 | FLUOROURACIL | 61 |
| 2 | FLUOROURACIL CREAM, 0.5% | 61 |
| 3 | OXALIPLATIN | 56 |
| 4 | CLOZAPINE | 41 |
| 5 | IRINOTECAN HYDROCHLORIDE | 33 |
| 6 | QUETIAPINE | 33 |
| 7 | RIVASTIGMINE | 31 |
| 8 | DIAZEPAM | 29 |
| 9 | LORAZEPAM | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEOSTIGMINE METHYLSULFATE | 7 | 0.0162 |
| 1 | QUAZEPAM | 4 | 0.0132 |
| 2 | MALATHION | 1 | 0.0099 |
| 3 | ECHOTHIOPHATE IODIDE FOR OPHTHALMIC SOLUTION | 1 | 0.0068 |
| 4 | ZIV-AFLIBERCEPT | 7 | 0.0054 |
| 5 | LEVOLEUCOVORIN INJECTION | 9 | 0.0029 |
| 6 | SACITUZUMAB GOVITECAN | 14 | 0.0029 |
| 7 | ATROPINE SULFATE INJECTION | 7 | 0.0028 |
| 8 | ATROPINE SULFATE MONOHYDRATE | 7 | 0.0028 |
| 9 | PYRIDOSTIGMINE BROMIDE | 21 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 77 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 71 |
| 2 | Platinum-based Drug [EPC] | 62 |
| 3 | Benzodiazepine [EPC] | 56 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 33 |
| 5 | Cholinesterase Inhibitor [EPC] | 32 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 7 | Corticosteroid [EPC] | 31 |
| 8 | Opioid Agonist [EPC] | 22 |
| 9 | Proton Pump Inhibitor [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cholinesterase Inhibitor [EPC] | 32 | 0.0017 |
| 1 | Anticholinergic [EPC] | 18 | 0.0011 |
| 2 | Cholinergic Muscarinic Agonist [EPC] | 2 | 0.0007 |
| 3 | Typical Antipsychotic [EPC] | 17 | 0.0007 |
| 4 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 6 | Cholinergic Muscarinic Antagonist [EPC] | 18 | 0.0005 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 19 | 0.0004 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 9 | Melatonin Receptor Agonist [EPC] | 4 | 0.0003 |